TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. (Q46026571)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. |
scientific article published in October 2009 |
Statements
TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma (English)
Fabrício de Carvalho
Manuella S Sampaio Almeida